Christine Falcoz

601 total citations
19 papers, 490 citations indexed

About

Christine Falcoz is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Infectious Diseases. According to data from OpenAlex, Christine Falcoz has authored 19 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 7 papers in Physiology and 4 papers in Infectious Diseases. Recurrent topics in Christine Falcoz's work include Inhalation and Respiratory Drug Delivery (8 papers), Asthma and respiratory diseases (7 papers) and Analytical Methods in Pharmaceuticals (4 papers). Christine Falcoz is often cited by papers focused on Inhalation and Respiratory Drug Delivery (8 papers), Asthma and respiratory diseases (7 papers) and Analytical Methods in Pharmaceuticals (4 papers). Christine Falcoz collaborates with scholars based in United Kingdom, United States and Italy. Christine Falcoz's co-authors include Alan Bye, Alison E. Mackie, Peter T. Daley‐Yates, H Möllmann, Bernd Meibohm, Hartmut Derendorf, Ruth Oliver, Günther Hochhaus, Mélanie Wagner and Jürgen Barth and has published in prestigious journals such as Journal of Clinical Oncology, Antimicrobial Agents and Chemotherapy and Journal of Pharmaceutical Sciences.

In The Last Decade

Christine Falcoz

19 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christine Falcoz United Kingdom 13 253 241 77 54 53 19 490
R. Siekmeier Germany 13 315 1.2× 73 0.3× 123 1.6× 52 1.0× 24 0.5× 17 578
Johannes Nagelschmitz Germany 12 299 1.2× 52 0.2× 20 0.3× 20 0.4× 42 0.8× 27 590
Bo Fredrikzon Sweden 13 75 0.3× 58 0.2× 44 0.6× 66 1.2× 22 0.4× 21 578
R A Yeates Germany 16 35 0.1× 63 0.3× 251 3.3× 75 1.4× 85 1.6× 35 692
Valvanera Vozmediano United States 11 25 0.1× 31 0.1× 54 0.7× 85 1.6× 51 1.0× 44 332
Sam Liao United States 14 16 0.1× 63 0.3× 58 0.8× 42 0.8× 97 1.8× 27 695
Elizabeth Migoya United States 13 76 0.3× 49 0.2× 235 3.1× 63 1.2× 139 2.6× 27 561
B. Kemmerich Germany 14 151 0.6× 70 0.3× 58 0.8× 17 0.3× 199 3.8× 29 513
Cora C. Barnett United States 12 99 0.4× 44 0.2× 41 0.5× 15 0.3× 18 0.3× 14 845
Allen Moton United States 8 72 0.3× 41 0.2× 359 4.7× 68 1.3× 84 1.6× 16 544

Countries citing papers authored by Christine Falcoz

Since Specialization
Citations

This map shows the geographic impact of Christine Falcoz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Falcoz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Falcoz more than expected).

Fields of papers citing papers by Christine Falcoz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Falcoz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Falcoz. The network helps show where Christine Falcoz may publish in the future.

Co-authorship network of co-authors of Christine Falcoz

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Falcoz. A scholar is included among the top collaborators of Christine Falcoz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Falcoz. Christine Falcoz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Meister, Isabel, et al.. (2018). Pharmacokinetics of Praziquantel in Schistosoma mansoni- and Schistosoma haematobium-Infected School- and Preschool-Aged Children. Antimicrobial Agents and Chemotherapy. 62(8). 19 indexed citations
2.
Latz, Jane E., Susumu Adachi, James T. Symanowski, et al.. (2007). PD4-3-4: Correlation of pemetrexed (PEM) NSCLC exposure-response relationships (ERRs) to clinical study results from western and Japanese patient populations. Journal of Thoracic Oncology. 2(8). S455–S456. 6 indexed citations
3.
Latz, Jane E., Laurent Claret, James T. Symanowski, et al.. (2007). Evaluation of pemetrexed (PEM) dosing paradigms using exposure-response relationships (ERRs). Journal of Clinical Oncology. 25(18_suppl). 2530–2530. 4 indexed citations
4.
Falcoz, Christine, J.M. Jenkins, Carole Bye, et al.. (2002). Pharmacokinetics of GW433908, a Prodrug of Amprenavir, in Healthy Male Volunteers. The Journal of Clinical Pharmacology. 42(8). 887–898. 42 indexed citations
5.
6.
Kirby, Suyong Yun, Christine Falcoz, Matthieu Daniel, et al.. (2001). Salmeterol and fluticasone propionate given as a combination. European Journal of Clinical Pharmacology. 56(11). 781–791. 40 indexed citations
7.
Goméni, Roberto, et al.. (2001). In-Silico Prediction of Drug Properties in Man Using Preclinical Data and Computer-Assisted Drug Development. Drug Information Journal. 35(4). 1047–1063. 5 indexed citations
8.
9.
Brindley, C., Christine Falcoz, Alison E. Mackie, & Alan Bye. (2000). Absorption Kinetics after Inhalation of Fluticasone Propionate via the Diskhaler??, Diskus?? and Metered-Dose Inhaler in Healthy Volunteers. Clinical Pharmacokinetics. 39(Supplement 1). 1–8. 25 indexed citations
10.
Falcoz, Christine, et al.. (2000). Bioavailability of Orally Administered Micronised Fluticasone Propionate. Clinical Pharmacokinetics. 39(Supplement 1). 9–15. 52 indexed citations
11.
Mackie, Alison E., et al.. (2000). Systemic Exposure to Fluticasone Propionate Administered via Metered-Dose Inhaler Containing Chlorofluorocarbon or Hydrofluoroalkane Propellant. Clinical Pharmacokinetics. 39(Supplement 1). 17–22. 28 indexed citations
12.
Falcoz, Christine, John Horton, Alison E. Mackie, Stuart M. Harding, & Peter T. Daley‐Yates. (2000). Pharmacokinetics of Fluticasone Propionate Inhaled via the Diskhaler?? and Diskus?? Powder Devices in Patients with Mild-to-Moderate Asthma. Clinical Pharmacokinetics. 39(Supplement 1). 31–37. 19 indexed citations
13.
Mackie, Alison E., et al.. (2000). Pharmacokinetics of Fluticasone Propionate Inhaled via the Diskhaler?? and Diskus?? Powder Devices in Healthy Volunteers. Clinical Pharmacokinetics. 39(Supplement 1). 23–30. 34 indexed citations
14.
Falcoz, Christine, et al.. (2000). Pharmacokinetics-Pharmacodynamics of a Sordarin Derivative (GM 237354) in a Murine Model of Lethal Candidiasis. Antimicrobial Agents and Chemotherapy. 44(9). 2333–2340. 22 indexed citations
15.
Wakefield, J. C., et al.. (1999). The Bayesian analysis of a pivotal pharmacokinetic study. Statistical Methods in Medical Research. 8(3). 195–216. 6 indexed citations
16.
Möllmann, H, Mélanie Wagner, Bernd Meibohm, et al.. (1998). Pharmacokinetic and pharmacodynamic evaluation of fluticasone propionate after inhaled administration. European Journal of Clinical Pharmacology. 53(6). 459–467. 54 indexed citations
17.
Rohatagi, Shashank, Alan Bye, Christine Falcoz, et al.. (1996). Dynamic Modeling of Cortisol Reduction after Inhaled Administration of Fluticasone Propionate. The Journal of Clinical Pharmacology. 36(10). 938–941. 46 indexed citations
18.
Falcoz, Christine, et al.. (1987). Pharmacokinetics of teicoplanin in renal failure. Antimicrobial Agents and Chemotherapy. 31(8). 1255–1262. 37 indexed citations
19.
Engasser, Jean‐Marc, et al.. (1981). Distribution, Metabolism, and Elimination of Phenobarbital in Rats: Physiologically Based Pharmacokinetic Model. Journal of Pharmaceutical Sciences. 70(11). 1233–1238. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Siekmeier Breakdown of academic impact, for papers by Johannes Nagelschmitz Breakdown of academic impact, for papers by Bo Fredrikzon Breakdown of academic impact, for papers by R A Yeates Breakdown of academic impact, for papers by Valvanera Vozmediano Breakdown of academic impact, for papers by Sam Liao Breakdown of academic impact, for papers by Elizabeth Migoya Breakdown of academic impact, for papers by B. Kemmerich Breakdown of academic impact, for papers by Cora C. Barnett Breakdown of academic impact, for papers by Allen Moton
Rankless by CCL
2026